| [1] |
Gu Qi, Rui Fajuan, Ni Qianqian, et al.
Chronic disease management in patients with nonalcoholic fatty liver diseases
[J]. Journal of Practical Hepatology, 2023, 26(4): 457-459.
|
| [2] |
Wang Zhuoya, Wu Yangpeng, Huang Yitao.
Observation of polyene phosphatidylcholine and zhibitai capsule combination in the treatment of patients with non-alcoholic fatty liver diseases
[J]. Journal of Practical Hepatology, 2023, 26(4): 496-499.
|
| [3] |
Yin Huifen, Yu Hongyan, Liu Zhiping.
Changes of serum leptin, retinol-binding protein-4 and cholinesterase levels in patients with NAFLD and T2DM
[J]. Journal of Practical Hepatology, 2023, 26(4): 500-503.
|
| [4] |
Zhao Lingling, Wang Beibei, Yao Yongli, et al..
Serum resistin and triacylglycerol glucose index in patients with T2DM and non-alcoholic fatty liver: their combination for progressive fibrosis
[J]. Journal of Practical Hepatology, 2023, 26(3): 356-359.
|
| [5] |
Huang Hui, Lin Min, Zeng Guixiang.
Hepatic ultrastructural features of paediatric Wilson’s disease, NAFLD and autoimmune hepatitis
[J]. Journal of Practical Hepatology, 2023, 26(3): 364-367.
|
| [6] |
Fan Mingfang, Tian Ying, Zhou Qian, et al..
Changes of serum RBP4 and SREBP-1c levels in patients with chronic hepatitis C and non-alcoholic fatty liver diseases
[J]. Journal of Practical Hepatology, 2023, 26(2): 185-188.
|
| [7] |
Fang Ying, Jin Jiadong, Wang Fu, et al..
Impact of COVID-19 pandemic on emotions and liver function tests in patients with nonalcoholic fatty liver diseases
[J]. Journal of Practical Hepatology, 2023, 26(2): 193-196.
|
| [8] |
Li Xiaomeng, Wu Shaoyu, Wang Yuanyuan.
Implication of serum homocystein, fibroblast growth factor-21 and nuclear factor-κB levels in patients with non-alcoholic fatty liver diseases and T2DM
[J]. Journal of Practical Hepatology, 2023, 26(2): 202-205.
|
| [9] |
Huang Danxia, Zhao Zhihui, Xiao Yuexing, et al.
Berberine improves liver injuries and intestinal flora disorders in high-fat diet-induced non-alcoholic fatty liver disease in rats
[J]. Journal of Practical Hepatology, 2023, 26(1): 23-26.
|
| [10] |
Xu Weiqiang, Liu Shuping, Li Xiaomeng.
Risk factors of non-alcoholic fatty liver diseases in physical examination individuals
[J]. Journal of Practical Hepatology, 2023, 26(1): 35-38.
|
| [11] |
Cai Yong, Li Jing, Ou Qin.
Implications of serum omentin, retinol-binding protein-4 and propeptide of type I procollagen in patients with diabetes mellitus type 2 and non-alcoholic fatty liver diseases
[J]. Journal of Practical Hepatology, 2022, 25(6): 800-803.
|
| [12] |
Sun Ling, Hang Wei, Deng Guozhong.
Short-term observation of metformin and pioglitazone combination in treatment of patients with non-alcoholic fatty liver diseases and diabetes mellitus type 2
[J]. Journal of Practical Hepatology, 2022, 25(6): 804-807.
|
| [13] |
Wang Xiaohua, Zeng Yalin, Guo Cuirong.
Impact of impaired fasting glucose and insulin resistance on liver fibrosis in patients with nonalcoholic fatty liver diseases
[J]. Journal of Practical Hepatology, 2022, 25(6): 812-815.
|
| [14] |
Fan Ye, Zhang Ximei, Zhang Yan.
Clinical implication of serum cystatin C, lipoprotein α and nesfatin-1 levels in patients with non-alcoholic fatty liver diseases
[J]. Journal of Practical Hepatology, 2022, 25(6): 816-819.
|
| [15] |
Zeng Ting, Lei Xiangyang, Bai Xiaosu.
Protective effect of oxymatrine on liver steatosis in rats with high-fat-induced non-alcoholic fatty liver diseases
[J]. Journal of Practical Hepatology, 2022, 25(5): 624-627.
|
